The aim of this study was to examine the independent relationship between serum uric acid (SUA) and blood pressure, and to assess their joint effects on obesity, fasting glucose and lipids. The study samples were from a community-based health examination survey in Xuzhou, Jiangsu province of China (2009). Blood pressure, body mass index, fasting glucose, lipids and SUA were measured. After excluding individuals with fasting glucose greater than 7 mmol l À1 , a total of 8415 subjects with biomarkers available were included in the present study. Blood pressure increased with elevated SUA levels, after adjusting for age and sex. Further adjustment for fasting glucose, lipids and alcohol consumption did not change the increasing trend. The associations between uric acid and hypertension were most evident in those with highest quintiles of high-density lipoprotein cholesterol (HDL-C). In addition, the associations were significant in both men and women, and we found significant interactions between uric acid status and age on hypertension. When the joint effects were examined, we found an additive effect of triglycerides and uric acid levels on diastolic blood pressure (DBP). There was significant association between SUA and hypertension, independent of other metabolic risk factors. HDL-C levels may modify the associations between uric acid and hypertension. The effects of triglycerides and uric acid levels on DBP were additive.
Introduction
In clinical and epidemiological studies, SUA has been found to be positively related not only to the risk of hypertension [1] [2] [3] but also to the risk of atherosclerosis, 4 cardiovascular diseases (CVDs) 5 and metabolic syndrome. 6 To prevent the incidence of hypertension effectively, it has become increasingly important to assign weightage to the influence of individual risk factors. Moreover, it is important to understand the interrelationships of various hypertension risk factors. In particular, the interactions between SUA, fasting glucose and lipids in relation to hypertension have not been fully examined. Not all epidemiological population studies support uric acid as an independent risk factor for hypertensive disease. The aim of this study was to evaluate the association between uric acid and hypertension in a large sample of Chinese population, and to assess the joint effects on obesity, fasting glucose, total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol.
A large body of evidence links SUA with obesity, insulin resistance, dyslipidemia and inflammation. 7, 8 These studies imply a hypothesis that uric acid might have synergistic effects with other risk factors during atherogenesis. We particularly assessed the interactions between SUA and other metabolic risk factors in relation to hypertension.
Methods

Population samples
In 2009, the Cardiometabolic Risk in Chinese (CRC) Study began the enrolment of 11 726 residents from a community-based health examination survey for individuals who were living in the urban area of Xuzhou, Jiangsu province of China. The CRC study was reviewed and approved by the ethics committee of the Central Hospital of Xuzhou, the Affiliated Hospital of Medical School of Southeast University, China. For the present study, we included adult men and women (X20 years) who were succesfully measured for blood pressure, body mass index (BMI), SUA and other metabolic markers (fasting glucose and lipids). Written consents were obtained from all the participants. We excluded patients with a fasting glucose of X7.0 mmol l À1 , and a total of 8415 subjects (4232 males, 4183 females) with available biomarkers were finally enrolled in this study.
Assessment of blood pressure Blood pressure was measured by doctors three times consecutively in the right arm, which was placed at the heart level, with a standard mercury sphygmomanometer, with the subject sitting still for more than 5 min. Three measurements, taken 60 s apart, were recorded. The average of the three values of systolic blood pressure (SBP) and diastolic blood pressure (DBP) was used in our analyses. We defined hypertension as SBPX140 mm Hg and DBPX90 mm Hg, or the use of antihypertensive medication, according to the seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-7).
Assessment of biomarkers and covariates
Venous blood sample was drawn from all subjects after an overnight fast (8-12 h). After blood was drawn, samples were allowed to clot at room temperature for 1-3 h and serum was separated. Immediately after clotting, serum was separated by centrifugation for 15 min at 3000 r.p.m. Fasting blood samples were collected for measurement of uric acid, glucose, total cholesterol, triglyceride, HDL-C and low-density lipoprotein cholesterol. All biochemical assays were determined enzymatically on an autoanalyzer (Type 7600, Hitachi Ltd, Tokyo, Japan). Height and body weight were measured with participants standing without shoes and heavy outer garments. BMI was calculated as weight (in kilograms) divided by height (in metres) squared.
Statistical analyses
Results are expressed as mean ± s.e. Comparisons between groups were made using one-way analysis of variance. General fasting glucose and triglyceride levels were logarithmically transformed to improve normality. We used unconditional logistic regression in estimating odds ratios for hypertension risk, adjusting for covariates including age, sex, BMI and biomarkers. The interactions between SUA and other factors were examined using the likelihood ratio test. All reported P-values were two tailed. Variables with P-values of o0.05 were considered statistically significant. Data management and statistical analysis were conducted using SAS statistical software (SAS 9.1.3, SAS Institute Inc., Cary, NC, USA).
Results
Correlation between SUA concentration and the clinical characteristics of the study population Subjects were divided into five groups according to their SUA levels (in quintiles). Some characteristics of the study population are shown in Table 1 . The study population was on an average 50.8 (20-91) years of age and had a mean BMI of 24.8 kg m À2 . The mean SBP was 129 mm Hg, with a range of 84-220 mm Hg, and DBP was 82 mm Hg, with a range of 49-136 mm Hg. All variables showed statistically significant differences between groups, with an increasing trend as the number of components increased (except for HDL-C, which showed a decreasing trend).
Correlations between SUA concentration and blood pressure Table 2 displays the mean blood pressure of subjects according to their SUA level in quintiles. Age-and sex-adjusted value for the means of SBP were 126.2 for the first, 128.0 for the second, 130.8 for the third, Table 1 Characteristics of participants by serum uric acid level (in quintiles) 
HDL-C modifies the associations between SUA concentration and hypertension
We next assessed the interactions between SUA and metabolic factors (BMI, fasting glucose, lipids and alcohol consumption) and performed stratified analyses (Table 3) . Considering the study power for the stratified analyses, we grouped the strata factors into three categories (tertiles): low, median and high levels. We found significant interactions between SUA and HDL-C in relation to hypertension risk (P for interaction ¼ 0.001). The associations between SUA and hypertension were significant in the group with a high level of SUA (P for trend ¼ 0.0001). The interaction tests for BMI, fasting glucose and total cholesterol were not significant (P for interaction 40.05).
Interactions between uric acid status and age on hypertension The associations between uric acid and hypertension were not different in men and women (P for interaction with sex 40.05). We examined Abbreviations: BMI, body mass index; HDL-C, high-density lipoprotein cholesterol. Analyses were adjusted for covariates age, sex, BMI, fasting glucose, total cholesterol, triglyceride, HDL-C and alcohol consumption, when they were not the strata variables.
Interaction between serum uric acid and triglycerides F Teng et al the associations between SUA and hypertension in different age categories: o40, 40-59 and X60 years (Table 3) . We found that the associations were significant in individuals of age o40 (Po0.0001), 40-59 (P ¼ 0.0019) and X60 years (P ¼ 0.0005). Test for the interaction between SUA and age was significant (P for interaction ¼ 0.006).
Joint effects of SUA and triglycerides on DBP
We also examined the joint effects of SUA and triglycerides on blood pressure. These two markers showed an additive effect on DBP ( Figure 1 ). As compared with the group with the lowest levels for both markers, individuals' mean DBP in the group with the highest levels of the two markers had 8 mm Hg higher DBP. However, we did not find an additive pattern with triglycerides and uric acid levels on SBP.
Discussion
In clinical and epidemiological studies, SUA has been found to be positively related to the risk of hypertension, [1] [2] [3] atherosclerosis, 4 CVDs 5 and metabolic syndrome. 6 Although several studies have found that an elevated uric acid level was an independent risk factor for hypertension, not all epidemiological population studies support uric acid as an independent risk factor for hypertensive disease. 9 Owing to lack of evidence, the precise role of SUA in the development of hypertension is yet unclear in the Chinese population. Thus, the aim of this study was to evaluate the independent relationship between SUA and blood pressure. We also found that the association was independent of other metabolic changes in glucose, lipids and alcohol consumption.
Hypertension is highly prevalent in Chinese people, and is becoming a leading cause of morbidity and mortality. 10 It has been suggested that uric acid may have a role in the pathogenesis of earlyonset hypertension. 11 Recent observations suggest that the association between uric acid and hypertension may, in fact, represent causation. 12 A study found that men with hyperuricemia had more risk for incident hypertension. 13 Each unit increase in SUA was associated with a 9% increase in the risk for incident hypertension. Although the mechanism by which uric acid has a pathogenetic role in hypertension was unclear; hyperuricemia was associated with deleterious effects on endothelial function, platelet adhesion and aggregation, or oxidative metabolism. 14 We found that the associations between SUA and hypertension were significant in the groups with high HDL-C. One out of every four women with hypertension aged X55 years had low HDL-C, and this was associated with a greater prevalence of overall CVD, and heart disease in particular. 15 The protective properties of HDL-C were well known. As well as participating in the inverse transport of cholesterol for its hepatic elimination, HDL-C particles possess antioxidant, anti-inflammatory and antithrombotic properties that protect against the development of atherosclerosis and CVD. 16 The association between uric acid and high brachialankle pulse wave velocity was observed both in subjects with metabolic syndrome and in those without. This study suggests that in both genders SUA level is associated with increased brachialankle pulse wave velocity, a marker of arterial stiffness, and is in part independent of other conventional risk factors for atherosclerosis and metabolic syndrome. 4 A recent study showed that higher SUA was closely linked to alterations in lipoprotein metabolism, which may represent an early sign of atherosclerosis in subjects. 17 In the stratified analyses, we also found significant interactions between uric acid status and age on hypertension. These results were not in line with data from the Health Professionals' Follow-up Study in which SUA levels were not associated with the risk of incident hypertension among elderly subjects (range 61-81 years). 16 The effects of high uric acid level on hypertension might be diminished at older age, when stiffening of the aorta may have a more important role. 18 Furthermore, increasing age is associated with activation of the renin-angiotensin system and with renal vasoconstriction; it is not surprising that the association between uric acid and hypertension may be blunted in older individuals.
The prevalence of obesity has increased markedly in the last decades. Obesity is closely related to hyperuricemia, as increased levels of insulin in obese subjects were associated with an enhanced sodium and uric acid reabsorption. 19 Measures of obesity including BMI and waist circumference Interaction between serum uric acid and triglycerides F Teng et al have been shown to be independent predictors of hyperuricemia, 20 and BMI showed a positive correlation with uric acid levels. 19 However, our study did not find significant interactions between uric acid status and BMI after stratified analysis. A previous study has found the strongest association between uric acid and SBP in the lowest quintiles of fasting glucose, 21 although we did not observe an interaction between fasting glucose and uric acid in our study. A prospective investigation of SUA and the risk of diabetes suggested a positive association between the plasma concentration of uric acid and the incidence of type 2 diabetes in Chinese individuals. 22 In our study, we did not find an interaction between SUA level and triglycerides in relation to hypertension. However, we found a joint effect of these two markers on DBP. A cross-sectional study of a consecutive sample of 3065 staff who had undergone health examination suggested that SUA level was highest in subjects with abnormal levels of triglycerides but an abnormal range of fasting glucose did not affect the SUA level. 23 In another study, the association of triglycerides and uric acid has been persistent after full adjustment in a multiple logistic model, suggesting that triglycerides correlate independently with uric acid level. Interestingly, the association was obtained even within the normal range of serum triglycerides. 24 The mechanism for the strong association between triglycerides and uric acid concentrations has not been elucidated.
Several pathogenetic mechanisms have been implicated in the association between SUA and hypertension. High SUA may lead to renal vasoconstriction through inhibition of the nitric oxide pathway and by activation of the renin-angiotensin system, 25 and then to increase in blood pressure. High triglyceride levels are highly correlated with CVD and insulin resistance, 26 and insulin resistance promotes the development of hypertension by stimulating renal tubular sodium reabsorption, augmenting sympathetic nervous system reactivity and activating the renin-angiotensin system. Reninangiotensin system activation is induced not only by triglycerides but also by uric acid concentration, and the two factors have joint effects on blood pressure. Apart from the joint effects that were examined, we also found an additive effect of triglyceride and uric acid levels on DBP. The difference in DBP between the two extreme groups (lowest quintiles versus highest quintiles for both markers) was 8 mm Hg.
Our study has the following limitations. First, this was a cross-sectional study that does not allow us to make an inference about the causal relationships between SUA concentration and hypertension. To confirm that the associations between uric acid and blood pressure are independent of other metabolic risk factors, a prospective study is needed. Second, the individuals were restricted to a communitybased health examination survey; hence the results of this study may not be applicable to the general population in China. Third, dietary habits may affect the SUA concentration, but were not evaluated in the present study population and so could not be evaluated in relation to SUA concentration.
In conclusion, we demonstrated significant associations between uric acid and hypertension in the Chinese population, independent of other metabolic risk factors. The associations between uric acid and hypertension were most evident in those with highest quintiles of HDL-C. We observed significant interactions between uric acid status and age on hypertension. The effects of uric acid and triglyceride on DBP were additive.
